Post Mastectomy Reconstruction denied as experimental or investigational by Blue Cross Blue Shield?
An experimental denial requires the appeal to cite the FDA approval (if any), peer-reviewed phase III data, and the recognised specialty-society guideline that supports the treatment for your indication.
US health-plan appeal rights
Cite: Most US health plans have appeal rights under either the ACA, ERISA, or Medicare/Medicaid rules
Most US health plans are required by federal law to give you both an internal appeal (where the insurer reconsiders) and an external review (where an independent reviewer decides). The exact timelines and processes depend on what kind of plan you have — marketplace / employer group, self-funded, Medicare Advantage, or Medicaid MCO — but in every case there's a window after the denial during which you have the right to fight it.
What Blue Cross Blue Shield typically requires
Blue Cross Blue Shield's specific coverage criteria for post mastectomy reconstruction are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.
The Blue Cross Blue Shield angle on Post Mastectomy Reconstruction
## Why BCBS Denied Post-Mastectomy Reconstruction as Experimental
An experimental or investigational denial means BCBS has determined that the specific reconstructive technique requested does not yet meet its threshold for established clinical evidence. This can arise when a particular surgical approach — such as a newer flap technique, an emerging implant technology, or a method recently refined by specialty societies — has not yet been incorporated into BCBS's medical policy as standard of care, even though it may be widely performed by reconstructive surgeons.
This type of denial is legally vulnerable in the context of post-mastectomy reconstruction because the Women's Health and Cancer Rights Act (WHCRA) of 1998 mandates coverage of reconstruction following mastectomy without carving out specific techniques as experimental when those techniques are performed by a qualified provider as part of an established reconstruction plan.
## Why It Is Appealable
The burden is on you to show that the technique your surgeon recommends is recognized as appropriate by relevant surgical and oncologic specialty organizations — such as the American Society of Plastic Surgeons or the American Society of Breast Surgeons — and is consistent with current clinical practice. You do not need to prove the technique is universally preferred, only that it is accepted, guideline-consistent, and medically indicated for your specific anatomy, prior treatment, and clinical circumstances.
## Federal Appeal Framework
- Internal appeal (ACA §2719 / ERISA §503): File a written internal appeal within the timeframe stated on the denial notice. You are entitled to a full-and-fair review by a clinician not involved in the original denial decision.
- External review (ACA §2719): If the internal appeal is denied, you have approximately four months from the final denial to request independent external review by an accredited organization.
- Expedited review: Request simultaneously with your internal appeal in writing if delay would materially harm your health or delay cancer-related surgery.
## Concrete Appeal Steps and Timeline
1. Obtain the specific policy language BCBS used to classify the technique as experimental. 2. Ask your surgeon to identify the relevant specialty society position statements or clinical practice guidelines endorsing the technique. 3. Assemble your packet and submit the internal appeal by the stated deadline. 4. If unsuccessful, proceed immediately to external review.
## Documentation to Gather
- Diagnosis and surgical history: Mastectomy operative report, oncology records, and any prior reconstructive procedures.
- Surgeon's technique justification: A detailed letter from your plastic surgeon explaining why this specific technique is medically appropriate for your anatomy and history, and how it is consistent with accepted surgical practice.
- Specialty society support: Position statements or practice guidelines from recognized surgical or oncology organizations endorsing the technique as appropriate — cited by organization name, not by specific numeric statistics.
- WHCRA citation: Your appeal letter should invoke the federal statute and note that WHCRA does not permit plans to exclude reconstruction techniques that are part of an accepted care plan.
- Second surgical opinion: If available, a second board-certified plastic surgeon's confirmation that the technique is standard for your presentation.
## Criteria-Mapping Structure
Obtain BCBS's current medical/coverage policy for post-mastectomy reconstruction and its definition of "experimental or investigational." List each criterion. For each one, document the specific chart fact, published guideline reference (by organization), or surgeon statement that demonstrates the technique does not meet that definition. Present this as a numbered checklist so the reviewer can confirm each element is addressed.
Next steps
- Find the date on the denial letter — your appeal window starts there.
- Read your plan's Summary of Benefits and Coverage (SBC) for the specific deadlines.
- Request the insurer's claim file in writing — they must provide it.
- Submit your appeal in writing with new clinical evidence and a physician statement.
Get the letter drafted
DenialHelp drafts your appeal in 5 minutes — $40 list price, $30 for your first letter (use code SEO25). We cite the federal regs and the specific clinical evidence your plan responds to. Your physician signs and sends.
Start my appeal — $30 with code SEO25 →Related appeal guides
- Blue Cross Blue Shield denied as experimental or investigational of 17ohp Compounded
- Blue Cross Blue Shield denied as experimental or investigational of AAT Augmentation
- Blue Cross Blue Shield denied as experimental or investigational of Amphetamine Stimulant Prodrug
- Blue Cross Blue Shield denied as experimental or investigational of Anti Cd 20 Ocrevus